OREX - Orexigen Therapeutics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 525M
Enterprise Value 3111.3M
Trailing P/E N/A
Forward P/E 1-0.24
PEG Ratio (5 yr expected) 10.00
Price/Sales (ttm)0.39
Price/Book (mrq)N/A
Enterprise Value/Revenue 31.76
Enterprise Value/EBITDA 6-0.68

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Jun 30, 2017
Profitability
Profit Margin -120.77%
Operating Margin (ttm)-270.38%
Management Effectiveness
Return on Assets (ttm)-40.01%
Return on Equity (ttm)N/A
Income Statement
Revenue (ttm)63.39M
Revenue Per Share (ttm)4.28
Quarterly Revenue Growth (yoy)199.80%
Gross Profit (ttm)25.71M
EBITDA -163.64M
Net Income Avi to Common (ttm)-76.55M
Diluted EPS (ttm)-5.1700
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)86.62M
Total Cash Per Share (mrq)5.61
Total Debt (mrq)171.53M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.73
Book Value Per Share (mrq)-2.76
Cash Flow Statement
Operating Cash Flow (ttm)-146.53M
Levered Free Cash Flow (ttm)74.05M

Trading Information

Stock Price History
Beta 2.35
52-Week Change 3-26.70%
S&P500 52-Week Change 317.43%
52 Week High 35.7000
52 Week Low 31.5500
50-Day Moving Average 31.7783
200-Day Moving Average 32.4321
Share Statistics
Avg Vol (3 month) 3190.86k
Avg Vol (10 day) 3258.48k
Shares Outstanding 515.43M
Float 10.96M
% Held by Insiders 10.14%
% Held by Institutions 145.47%
Shares Short 32.16M
Short Ratio 330.24
Short % of Float 325.77%
Shares Short (prior month) 32.24M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/10
Last Split Date 3Jul 12, 2016